Factors affecting breast cancer risk reduction practices among California physicians

Preventive Medicine

Volumn 41, Issue 1, 2005, Pages 7-15

  Kaplan, Celia Patricia ^a   Haas, Jennifer S ^b   Pérez Stable, Eliseo J ^a   Des Jarlais, Genevieve ^a   Gregorich, Steven E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Counseling; Genetic screening; Physician's practice patterns; Raloxifene; Risk reduction; Tamoxifen

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CLINICAL PRACTICE; CONTROLLED STUDY; FAMILY MEDICINE; FEMALE; GENETIC SCREENING; GYNECOLOGY; HEALTH SURVEY; HUMAN; INTERNAL MEDICINE; MALE; MEDICAL EDUCATION; MULTIVARIATE ANALYSIS; OBSTETRICS; PATIENT COUNSELING; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK REDUCTION; SELF EVALUATION; TREATMENT OUTCOME; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; CALIFORNIA; FEMALE; GENETIC COUNSELING; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; MALE; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 19944420840     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.09.041     Document Type: Article

References (35)

1. B. Fisher, J.P. Costantino, and D.L. Wickerham Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90 1998 1371 1388
2. R.T. Chlebowski, D.E. Collyar, M.R. Somerfield, and D.G. Pfister American society of clinical oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene J. Clin. Oncol. 17 1999 1939 1955
3. M. Levine, J.M. Moutquin, R. Walton, and J. Feightner Chemoprevention of breast cancer. A joint guideline from the Canadian task force on preventive health care and the Canadian breast cancer initiative's steering committee on clinical practice guidelines for the care and treatment of breast cancer CMAJ 164 2001 1681 1690
4. L.S. Kinsinger, R. Harris, S.H. Woolf, H.C. Sox, and K.N. Lohr Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force Ann. Intern. Med. 137 2002 59 69
5. Y. Miki, J. Swensen, and D. Shattuck-Eidens A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
6. M.L. Slattery, and R.A. Kerber A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database JAMA 270 1993 1563 1568
7. L.C. Hartmann, D.J. Schaid, and J.E. Woods Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N. Engl. J. Med. 340 1999 77 84
8. M. Mezzetti, C. La Vecchia, A. Decarli, P. Boyle, R. Talamini, and S. Franceschi Population attributable risk for breast cancer: diet, nutrition, and physical exercise J. Natl. Cancer Inst. 90 1998 389 394
9. M.D. Gammon, E.M. John, and J.A. Britton Recreational and occupational physical activities and risk of breast cancer J. Natl. Cancer Inst. 90 1998 100 117
10. Z. Huang, S.E. Hankinson, and G.A. Colditz Dual effects of weight and weight gain on breast cancer risk JAMA 278 1997 1407 1411
11. S.A. Smith-Warner, D. Spiegelman, and S.S. Yaun Alcohol and breast cancer in women: a pooled analysis of cohort studies JAMA 279 1998 535 540
12. T. Powles, R. Eeles, and S. Ashley Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial Lancet 352 1998 98 101
13. U. Veronesi, P. Maisonneuve, and A. Costa Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study Lancet 352 1998 93 97
14. K.M. Newton, A.Z. Lacroix, S.G. Leveille, C. Rutter, N.L. Keenan, and L.A. Anderson The physician's role in women's decision making about hormone replacement therapy Obstet. Gynecol. 92 1998 580 584
15. S.E. McNagny, and T.A. Jacobson Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion Arch. Intern. Med. 157 1997 1337 1342
16. J. Draper, and M. Roland Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis BMJ 300 1990 786 788
17. A.Y. Kinney, C. Richards, S.W. Vernon, and V.G. Vogel The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial Prev. Med. 27 1998 713 719
18. B.K. Dunn, and L.G. Ford From adjuvant therapy to breast cancer prevention: BCPT and STAR Breast J. 7 2001 144 157
19. S.G. Pappas, and V.C. Jordan Chemoprevention of breast cancer: current and future prospects Cancer Metastasis Rev. 21 2002 311 321
20. L.C. Friedman, H.P. Cooper, J.A. Webb, A.D. Weinberg, and S.E. Plon Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results J. Cancer Educ. 18 2003 91 94
21. M. Escher, and A.P. Sappino Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition Ann. Oncol. 11 2000 1131 1135
22. A. Fry, H. Campbell, and H. Gudmunsdottir GPs' views on their role in cancer genetics services and current practice Fam. Pract. 16 1999 468 474
23. T. Doksum, B.A. Bernhardt, and N.A. Holtzman Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet. Med. 5 2003 99 105
24. S. Kripalani, A.D. Weinberg, and H.P. Cooper Screening for breast and prostate cancer: a survey of Texas primary care physicians Tex. Med. 92 1996 59 67
25. K.L. Dominick, C.S. Skinner, L.A. Bastian, H.B. Bosworth, T.S. Strigo, and B.K. Rimer Provider characteristics and mammography recommendation among women in their 40s and 50s J. Womens Health (Larchmt) 12 2003 61 71
26. E. Moy, and B.A. Bartman Physician race and care of minority and medically indigent patients JAMA 273 1995 1515 1520
27. B.A. Bernhardt, and R.E. Pyeritz The organization and delivery of clinical genetics services Pediatr. Clin. North Am. 39 1992 1 12
28. R.A. Pagon, P. Tarczy-Hornoch, and P.K. Baskin GeneTests-GeneClinics: genetic testing information for a growing audience Hum. Mutat. 19 2002 501 509
29. M.F. Myers, T. Doksum, and N.A. Holtzman Genetic services for common complex disorders: surveys of health maintenance organizations and academic genetic centers Genet. Med. 1 1999 272 285
30. J. Mouchawar, C.E. Klein, and L. Mullineaux Colorado family physicians' knowledge of hereditary breast cancer and related practice J. Cancer Educ. 16 2001 33 37
31. B.B. Johnson, and P. Slovic Presenting uncertainty in health risk assessment: initial studies of its effects on risk perception and trust Risk Anal. 15 1995 485 494
32. P.M. Sandman, N.D. Weinstein, and P. Miller High risk or low: how location on a "risk ladder" affects perceived risk Risk Anal. 14 1994 35 45
33. S.L. Sheridan, and M. Pignone Numeracy and the medical student's ability to interpret data Effect Clin. Pract. 5 2002 35 40
34. B. Woo, E.F. Cook, M. Weisberg, and L. Goldman Screening procedures in the asymptomatic adult. Comparison of physicians' recommendations, patients' desires, published guidelines, and actual practice JAMA 254 1985 1480 1484
35. J.S. Schwartz, C.E. Lewis, C. Clancy, M.S. Kinosian, M.H. Radany, and J.P. Koplan Internists' practices in health promotion and disease prevention. A survey Ann. Intern. Med. 114 1991 46 53